Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fertility drug study compares how japanese and caucasian women process medication

NCT ID NCT07269327

First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 30 times

Summary

This study looked at how the body absorbs and processes a single dose of Pergoveris, a fertility drug containing two hormones (FSH and LH), in 24 healthy women of Japanese or Caucasian origin. Participants took a birth control pill for about 4 weeks to suppress their natural hormones, then received one injection of Pergoveris. The goal was to measure drug levels in the blood and check for side effects, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FERTILITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fortrea Clinical Research Unit Ltd

    Leeds, United Kingdom

Conditions

Explore the condition pages connected to this study.